TWST — Twist Bioscience Share News
0.000.00%
Last trade - 00:00- $9.58bn
- $9.41bn
- $376.57m
Brief: Twist Bioscience Expands Express Genes Rapid Synthesis Service
U.S. RESEARCH ROUNDUP- Compass Minerals International, Equinix, Kingstone Companies
U.S. STOCKS ON THE MOVE-Primerica, Canopy Growth, Applied Materials
U.S. STOCKS ON THE MOVE-Copart, Expedia, Chevron
Twist Bioscience rises as Q4 rev beats estimates
Corrected: BRIEF-Twist Bioscience Q4 EPS USD -0.81
Brief: Twist Bioscience Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Brief: Twist Bioscience Enters Into Antibody Discovery And Licensing Option Agreement With Bayer Of Up To $188 Mln
U.S. STOCKS ON THE MOVE-Nucor, Liberty Energy, Micron Technology
U.S. STOCKS ON THE MOVE-SoundHound, Tesla, Energy firms
Twist Bioscience rises on collaboration for antibody discovery
Brief: Twist Bioscience And Imidomics Collaborate To Discover Antibodies For Applications In Immune-Mediated Inflammatory Diseases
U.S. RESEARCH ROUNDUP-Docusign, Immunovant, Liberty Energy
Twist Bioscience Corp reports results for the quarter ended in June - Earnings Summary
Brief: Twist Bioscience Thorburn Will Transition To New Role After New CFO Appointed
Brief: Twist Bioscience Reports Fiscal Third Quarter 2023 Financial Results
Brief: Twist Bioscience Q3 EPS USD -1.01
Twist Bioscience Corp expected to post a loss of $1.14 a share - Earnings Preview
Brief: Twist Bioscience And Cancer Research Horizons Enter Into Collaboration